Атеротромбоз
«REMEDIUM GROUP» Ltd. · Russian Federation · Est. 2016
Aims & Scope✦ Inferred from recent articles
The journal focuses on the diagnosis, risk assessment, and treatment of cardiovascular diseases, particularly those involving thrombosis and atherosclerosis. It covers topics such as pulmonary embolism, deep vein thrombosis, myocardial infarction, and atrial fibrillation. The scope includes the use of anticoagulants and antiplatelet therapies, surgical interventions for vascular diseases, and the management of complications like bleeding and thromboembolism. The journal also addresses the impact of comorbidities such as diabetes and cancer on cardiovascular health and treatment outcomes.
AI-summarised from recent articles · verify on publisher page →
General Information
Submission Info
Ethics & Quality
Think.Check.Submit Compliance
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Subject Classification
Research Topics (OpenAlex)
You May Also Like
See all →Data updated: 2026-05-26 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref